Former STAR PhD Fellow
Marianne Ølholm Larsen Grønning
Current position: Project Vice President
I applied for a STAR Industrial PhD fellowship at Novo Nordisk
because it gave me the opportunity to combine academic and industrial
research. Both back then and today I appreciate that the research
being done in the laboratory has a direct impact on projects aiming at
providing new and better ways to treat diabetes.
I did my PhD from 1998-2001 as a STAR fellow. The focus of my
project was to develop a model of diabetes to be used at Novo Nordisk.
Right from the beginning, I became part of a Novo Nordisk research
project team, which was very motivating and gave me the possibility to
learn a lot about the research strategies of Novo Nordisk. As a STAR
fellow it is good to know that you are working on something extremely
I had the opportunity to attend international conferences and use the extensive Novo Nordisk scientific network within diabetes to collaborate with internationally acknowledged experts within my field of research. This was an excellent way of learning and getting inspired.
After my PhD I continued doing research within the same field. It
was a great feeling to see the models that I had worked on during my
PhD actually being used in several of our research projects. This was
exactly what I had hoped for, when I was spending the long hours in
the lab during my PhD time. I was fortunate to be in a position, where
I could continue my research on models of diabetes. Based on the
extensive results from this work I ended up doing a Doctor of Medical
Science degree. I have continued to work with these models in many
different project teams but at the same time I have taken on new
challenges within R&D management.
From the beginning of 2010 I have taken on a new and exciting challenge by moving to Beijing to start a diabetes research unit at our R&D centre located in the ZhongGuanCun Life Science Park. The possibility to combine my experience from our research organisation with a stay abroad has been a wish for me for many years. Things are different here, but like in R&D labs in Denmark, I find myself among a group of great colleagues, who have helped me feel welcome and at home here in Beijing.
Mads Krogsgaard Thomsen, Chief Science Officer at Novo Nordisk, talks about the need to attract the best scientific talent from around the world.
Read more about our R&D strategy and research pipeline and our
latest research publications at our dedicated